People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DarioHealth Corp. | — | Biotechnology | Series C | $286.5M | $97.8M | 2013 |
| Dance Biopharm Holdings, Inc. | — | Biotechnology | Series B | $87.5M | $9.6M | 2015 |
| PROLOR Biotech, Inc. | — | Biotechnology | Series B | $26.4M | $968.4M | 2010 |
Adam D. Stern at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam D. Stern on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adam Stern | 2 | 4 |
| Adam K Stern | 2 | 4 |
| Richard Anderson | 1 | 10 |
| Steven D. Rubin | 1 | 9 |
| Richard Stone | 1 | 6 |
| JANE H HSIAO | 1 | 5 |
| Dennis M McGrath | 1 | 5 |
| Steven Nelson | 1 | 5 |
| Gadi Levin | 1 | 5 |
| Dennis McGrath | 1 | 4 |
| Malcolm Hoenlein | 1 | 4 |
| Peter Kash | 1 | 4 |
| Phillip Frost | 1 | 3 |
| Chen Franco-Yehuda | 1 | 3 |
| Steven Kaplan | 1 | 3 |
| John S. Patton | 1 | 3 |
| Donald D. Huffman | 1 | 3 |
| Allen Kamer | 1 | 3 |
| Greg S. Zante | 1 | 2 |
| Hila Karah | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.